PREVEST
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Prevest Denpro Says Dividend 1 Rupee Per Share
Aug 3 (Reuters) - PREVEST DENPRO LTD PREV.BO:
DIVIDEND 1 RUPEE PER SHARE
Source text for Eikon: ID:nBSEbvPt5c
Further company coverage: PREV.BO
(([email protected];;))
Aug 3 (Reuters) - PREVEST DENPRO LTD PREV.BO:
DIVIDEND 1 RUPEE PER SHARE
Source text for Eikon: ID:nBSEbvPt5c
Further company coverage: PREV.BO
(([email protected];;))
Events:
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Prevest Denpro do?
Prevest Denpro Limited produces a wide range of dental materials to diagnose, treat, and prevent dental conditions, catering to various dentistry fields. Its products are distributed across Europe, Asia, South America, Middle East, and Africa.
Who are the competitors of Prevest Denpro?
Prevest Denpro major competitors are Venus Remedies, Sakar Healthcare, Kilitch Drugs(India), Ind-Swift Lab., Shivalik Rasayan, Jenburkt Pharma, Wanbury. Market Cap of Prevest Denpro is ₹658 Crs. While the median market cap of its peers are ₹771 Crs.
Is Prevest Denpro financially stable compared to its competitors?
Prevest Denpro seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Prevest Denpro pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Prevest Denpro latest dividend payout ratio is 7.44% and 3yr average dividend payout ratio is 7.54%
How has Prevest Denpro allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments
How strong is Prevest Denpro balance sheet?
Balance sheet of Prevest Denpro is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Prevest Denpro improving?
Yes, profit is increasing. The profit of Prevest Denpro is ₹18.89 Crs for TTM, ₹16.14 Crs for Mar 2024 and ₹15.71 Crs for Mar 2023.
Is the debt of Prevest Denpro increasing or decreasing?
Yes, The debt of Prevest Denpro is increasing. Latest debt of Prevest Denpro is -₹60.9 Crs as of Mar-25. This is greater than Mar-24 when it was -₹97.06 Crs.
Is Prevest Denpro stock expensive?
Prevest Denpro is not expensive. Latest PE of Prevest Denpro is 36.23, while 3 year average PE is 38.0. Also latest EV/EBITDA of Prevest Denpro is 26.09 while 3yr average is 31.39.
Has the share price of Prevest Denpro grown faster than its competition?
Prevest Denpro has given lower returns compared to its competitors. Prevest Denpro has grown at ~16.8% over the last 3yrs while peers have grown at a median rate of 28.76%
Is the promoter bullish about Prevest Denpro?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Prevest Denpro is 73.6% and last quarter promoter holding is 73.6%.
Are mutual funds buying/selling Prevest Denpro?
There is Insufficient data to gauge this.